Paraurethral Gland, Overlapping Lesion of Urinary Organs, and Unspecified Urinary Organs
Primary Site | Histology | Staging Type |
---|---|---|
C681, C688-C689 | 8000-9136, 9141-9582, 9700-9701 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C681 Paraurethral gland C688 Overlapping lesion of urinary organs C689 Urinary system, NOS **Note 1:** Transitional cell carcinoma (8120-8130) of the prostatic ducts and prostatic urethra are to be coded to urethra (C680) and Summary Stage according to that schema. **Note 2:** TNM is not defined for this schema. If directly assigning Summary Stage 2000 (SS2000), use the *Urethra, Paraurethral Gland, and Unspecified Urinary Organs* chapter on page 254 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=254).Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item |
---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | |
Derived SEER Clin Stage Group | 88 | NAACCR #3610 | |
Derived SEER Path Stage Group | 88 | NAACCR #3605 | |
Derived SEER Combined Stage Group | 88 | NAACCR #3614 | |
Derived SEER Combined T | 88 | NAACCR #3616 | |
Derived SEER Combined N | 88 | NAACCR #3618 | |
Derived SEER Combined M | 88 | NAACCR #3620 | |
Derived SEER Combined T Source | <BLANK> | NAACCR #3622 | |
Derived SEER Combined N Source | <BLANK> | NAACCR #3624 | |
Derived SEER Combined M Source | <BLANK> | NAACCR #3626 |